Canswerist® — BMT/SCT: Surviving MCL 2006–2026 Canswerist ® BMT/SCT: Surviving MCL 2006–2026 Searching for answers. Finding hope. Writing the journey. In 2006, a diagnosis of mantle cell lymphoma (MCL) often arrived with sobering statistics and limited treatment options. For patients with aggressive or relapsed disease, one procedure represented both extraordinary risk and extraordinary hope: blood and marrow transplantation (BMT) , also known as stem cell transplantation (SCT) . Twenty years later, the landscape has changed dramatically. Today’s therapies include targeted drugs, CAR-T cell therapy, bispecific antibodies, and highly personalized immunotherapies. Yet none of these remarkable advances diminish the importance of what BMT/SCT accomplished during the early years of modern lymphoma treatment. In many ways, today’s progress stands upon the foundation built by transplant medicine and the courage of those who underwent it. The 2006 transplant journey was d...

  What Do We Know About Diabetes Today? New Research Reveals Growing Risks, Better Prevention, and Emerging Hope Diabetes remains one of the most significant health challenges of our time. While advances in medicine continue to improve treatment options, recent research suggests that prevention, lifestyle intervention, and early detection may be even more powerful than many people realize. According to recent diabetes-related reporting and research reviews, millions of Americans are either living with diabetes or are on the path toward developing it. At the same time, scientists are uncovering new clues about insulin resistance, nutrition, exercise, medications, and the possibility of reversing Type 2 diabetes in some individuals. The Diabetes Landscape Continues to Expand Researchers estimate that nearly 115 million Americans are at risk of developing diabetes, while global rates continue to rise. Diabetes diagnoses in the United States have reached historic highs, even as obesity...

  T he infographic summary (above) of the Healthcare Decoded Series  by the EPOCH TIMES (subscription may be required) highlights major structural problems and proposed reforms within the modern healthcare system. Main Themes Covered A System in Crisis Rising healthcare costs, declining health outcomes, and public distrust are examined as signs of systemic failure. Follow the Money Financial incentives, lobbying, and corporate interests strongly influence healthcare policies and treatment decisions. Conflicts of Interest The relationship between regulators, pharmaceutical companies, and institutions can compromise public trust and objectivity. The Drug Paradigm Modern medicine is often criticized for focusing heavily on symptom management through medication rather than root causes. Hospitals Built to Bill Hospitals are portrayed as increasingly profit-driven systems where billing structures can overshadow patient care. Captured by Big Pharma Pharmaceutical in...